Nephrology studies require nuance and precision, not just execution.
Our teams deliver disciplined operations and transparent oversight — with global experience in rare and chronic renal disorders.
Why Biorasi for Nephrology?
Nephrology trials often involve specialized labs, biopsy-based eligibility, and unique patient pathways. Biorasi delivers oversight and integration across these touchpoints, with real-time reporting dashboards and seasoned leadership guiding every phase.
Subspecialties
- Rare kidney disease
- Chronic Kidney Disease (CKD)
- Acute Kidney Injury (AKI)
- Renal outcomes in obesity and heart failure
- Immunologic and inflammatory renal disease
Proof of
Performance
- 16 Studies
- 10 Indications
- 1,277 Patients Enrolled
Case Studies and Results
- Global C3G Trial (C3 Glomerulopathy)
- 48 patients at 17 sites
- Multiple protocol reviews and revisions
- Over-recruited in a globally dispersed population
- Integrated medical monitoring and vendor coordination ensured trial stability
FROM OUR PARTNERS
Jennifer Simpson 2
“The Biorasi team maintained constant communication, remained agile in their approach, and most im…Read More
Jennifer Simpson 2
“The Biorasi team maintained constant communication, remained agile in their approach, and most importantly, showed genuine investment in our project’s success. I couldn’t have asked for a better partner.”
Jennifer Simpson
Biotech Leader
